GSK3B and colorectal carcinoma: Notably, our current data show that Gankyrin was upregulated in CRCs, which induced CRC cells proliferation, angiogenesis, chemoresistance and metastasis, by activating PI3K/GSK-3β/β-catenin signal, concordantly, promotion of CRC aggressiveness in vitro and in vivo.